Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 1
2006 2
2007 6
2008 12
2009 11
2010 10
2011 4
2012 6
2013 7
2014 4
2015 2
2016 2
2017 1
2018 4
2019 7
2020 6
2021 4
2022 4
2023 9
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Results by year

Filters applied: . Clear all
Page 1
Non-alcoholic fatty liver disease.
Maurice J, Manousou P. Maurice J, et al. Among authors: manousou p. Clin Med (Lond). 2018 Jun;18(3):245-250. doi: 10.7861/clinmedicine.18-3-245. Clin Med (Lond). 2018. PMID: 29858436 Free PMC article. Review.
Response.
Maurice JB, Manousou P. Maurice JB, et al. Among authors: manousou p. Clin Med (Lond). 2018 Oct;18(5):440. doi: 10.7861/clinmedicine.18-5-440. Clin Med (Lond). 2018. PMID: 30287450 Free PMC article. No abstract available.
Screening for NAFLD-Current Knowledge and Challenges.
Forlano R, Sigon G, Mullish BH, Yee M, Manousou P. Forlano R, et al. Among authors: manousou p. Metabolites. 2023 Apr 9;13(4):536. doi: 10.3390/metabo13040536. Metabolites. 2023. PMID: 37110194 Free PMC article. Review.
Another arrow in the NASH quiver?
Forlano R, Manousou P. Forlano R, et al. Among authors: manousou p. Lancet Gastroenterol Hepatol. 2023 Feb;8(2):96-97. doi: 10.1016/S2468-1253(22)00383-1. Epub 2022 Dec 12. Lancet Gastroenterol Hepatol. 2023. PMID: 36521502 No abstract available.
Non-Alcoholic Fatty Liver Disease and Vascular Disease.
Forlano R, Mullish BH, Nathwani R, Dhar A, Thursz MR, Manousou P. Forlano R, et al. Among authors: manousou p. Curr Vasc Pharmacol. 2021;19(3):269-279. doi: 10.2174/1570161118666200318103001. Curr Vasc Pharmacol. 2021. PMID: 32188385 Review.
Detection of senescence using machine learning algorithms based on nuclear features.
Duran I, Pombo J, Sun B, Gallage S, Kudo H, McHugh D, Bousset L, Barragan Avila JE, Forlano R, Manousou P, Heikenwalder M, Withers DJ, Vernia S, Goldin RD, Gil J. Duran I, et al. Among authors: manousou p. Nat Commun. 2024 Feb 3;15(1):1041. doi: 10.1038/s41467-024-45421-w. Nat Commun. 2024. PMID: 38310113 Free PMC article.
Non-alcoholic fatty liver disease and cardiovascular risk: an update.
Mullish BH, Forlano R, Manousou P, Mikhailidis DP. Mullish BH, et al. Among authors: manousou p. Expert Rev Gastroenterol Hepatol. 2018 Dec;12(12):1175-1177. doi: 10.1080/17474124.2018.1533117. Epub 2018 Oct 16. Expert Rev Gastroenterol Hepatol. 2018. PMID: 30791787 Free article. No abstract available.
Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipients.
Murray SM, Pose E, Wittner M, Londoño MC, Schaub G, Cook J, Dimitriadis S, Meacham G, Irwin S, Lim Z, Duengelhoef P, Sterneck M, Lohse AW, Perez V, Trivedi P, Bhandal K, Mullish BH, Manousou P, Provine NM, Avitabile E, Carroll M, Tipton T, Healy S, Burra P, Klenerman P, Dunachie S, Kronsteiner B, Maciola AK, Pasqual G, Hernandez-Gea V, Garcia-Pagan JC, Lampertico P, Iavarone M, Gines P, Lütgehetmann M, Schulze Zur Wiesch J, Russo FP, Barnes E, Marjot T; OCTAVE Collaborative Group, PITCH study, and the EASL supported COVID-Hep vaccine network. Murray SM, et al. Among authors: manousou p. J Hepatol. 2024 Jan;80(1):109-123. doi: 10.1016/j.jhep.2023.10.009. Epub 2023 Oct 19. J Hepatol. 2024. PMID: 37863203 Free PMC article.
88 results